药物防治糖皮质激素性骨质疏松的规范性及影响因素分析
中图分类号R977.1+1 文献标志码A 文章编号 1001-0408(2025)08-0991-05DOI 10.6039/j.issn.1001-0408.2025.08.18
Analysis of the standardizationand influential factors in the prevention and treatment of glucocorticoidinduced osteoporosis with drugs
JIANG Wenshuo'2,LIU Chen', ZENG Yan'(1. Dept. of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100037, China; 2. College of Pharmacy, Capital Medical University, Beijing 100069, China)
ABSTRACTOBJECTIVEToanalyze the standardizationandinfluentialfactors medicationuseforthe preventionandtreatent of glucocorticoid-inducedosteoporosis(GIOP)METHODSThedataof inpatientsdiagnosed asrheumaticimmunediseases inour hospitalfromJanuary22,toDecember3,02whorequiredlong-termuseofglucocorticoids,werecolectedtoanalyze theriskstratifationforGOrelatedfracturesandtheutilizationofpreventinandtreatmentdrginpatientsUnivariateanalysis andLogisticstepwiseregressionanalysiswereemployedtoscreenthefactorsinfluencingthestandardizationofpreventionand treatment drug use in patients. RESULTS Among 354 patients, 148 patients (41.81% )had a low risk of osteoporotic fractures ......
您现在查看是摘要页,全文长 19691 字符。